408 related articles for article (PubMed ID: 8759757)
41. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway.
Badolato R; Johnston JA; Wang JM; McVicar D; Xu LL; Oppenheim JJ; Kelvin DJ
J Immunol; 1995 Oct; 155(8):4004-10. PubMed ID: 7561109
[TBL] [Abstract][Full Text] [Related]
42. S100 protein CP-10 stimulates myeloid cell chemotaxis without activation.
Cornish CJ; Devery JM; Poronnik P; Lackmann M; Cook DI; Geczy CL
J Cell Physiol; 1996 Feb; 166(2):427-37. PubMed ID: 8592003
[TBL] [Abstract][Full Text] [Related]
43. Cellular receptors to the anaphylatoxins C3a and C5a.
Huey R; Fukuoka Y; Hoeprich PD; Hugli TE
Biochem Soc Symp; 1986; 51():69-81. PubMed ID: 3545212
[TBL] [Abstract][Full Text] [Related]
44. Signal transduction in human alveolar macrophages: diminished chemotactic response to FMLP correlates with a diminished density of Gi proteins and FMLP receptors.
Beaty CD; Martin TR; Wilson CB
Am J Respir Cell Mol Biol; 1991 Jul; 5(1):87-92. PubMed ID: 1908689
[TBL] [Abstract][Full Text] [Related]
45. Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a.
Van Epps DE; Simpson SJ; Johnson R
J Immunol; 1993 Jan; 150(1):246-52. PubMed ID: 8417126
[TBL] [Abstract][Full Text] [Related]
46. A neuronal C5a receptor and an associated apoptotic signal transduction pathway.
Farkas I; Baranyi L; Takahashi M; Fukuda A; Liposits Z; Yamamoto T; Okada H
J Physiol; 1998 Mar; 507 ( Pt 3)(Pt 3):679-87. PubMed ID: 9508829
[TBL] [Abstract][Full Text] [Related]
47. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin.
Buchner RR; Hugli TE; Ember JA; Morgan EL
J Immunol; 1995 Jul; 155(1):308-15. PubMed ID: 7541417
[TBL] [Abstract][Full Text] [Related]
48. Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton.
Nolte C; Möller T; Walter T; Kettenmann H
Neuroscience; 1996 Aug; 73(4):1091-107. PubMed ID: 8809827
[TBL] [Abstract][Full Text] [Related]
49. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
el-Lati SG; Dahinden CA; Church MK
J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
[TBL] [Abstract][Full Text] [Related]
50. Mutation of aspartate 82 of the human C5a receptor abolishes the secretory response to human C5a in transfected rat basophilic leukemia cells.
Monk PN; Pease JE; Marland G; Barker MD
Eur J Immunol; 1994 Nov; 24(11):2922-5. PubMed ID: 7957584
[TBL] [Abstract][Full Text] [Related]
51. Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a.
Kretzschmar T; Jeromin A; Gietz C; Bautsch W; Klos A; Köhl J; Rechkemmer G; Bitter-Suermann D
Eur J Immunol; 1993 Feb; 23(2):558-61. PubMed ID: 7679650
[TBL] [Abstract][Full Text] [Related]
52. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
53. Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis.
Ghebrehiwet B; Kew RR; Gruber BL; Marchese MJ; Peerschke EI; Reid KB
J Immunol; 1995 Sep; 155(5):2614-9. PubMed ID: 7650391
[TBL] [Abstract][Full Text] [Related]
54. Role of C3a and C5a in the activation of mast cells.
Erdei A; Kerekes K; Pecht I
Exp Clin Immunogenet; 1997; 14(1):16-8. PubMed ID: 9187918
[TBL] [Abstract][Full Text] [Related]
55. Phosphorylation, dephosphorylation, and recycling of the C5a receptor in differentiated HL60 cells.
Giannini E; Boulay F
J Immunol; 1995 Apr; 154(8):4055-64. PubMed ID: 7706744
[TBL] [Abstract][Full Text] [Related]
56. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
57. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation.
McCoy R; Haviland DL; Molmenti EP; Ziambaras T; Wetsel RA; Perlmutter DH
J Exp Med; 1995 Jul; 182(1):207-17. PubMed ID: 7540650
[TBL] [Abstract][Full Text] [Related]
58. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response.
Nilsson G; Metcalfe DD; Taub DD
Immunology; 2000 Feb; 99(2):314-9. PubMed ID: 10692052
[TBL] [Abstract][Full Text] [Related]
59. Serum amyloid A induces chemotaxis of human mast cells by activating a pertussis toxin-sensitive signal transduction pathway.
Olsson N; Siegbahn A; Nilsson G
Biochem Biophys Res Commun; 1999 Jan; 254(1):143-6. PubMed ID: 9920747
[TBL] [Abstract][Full Text] [Related]
60. Nature and functioning of the pertussis toxin-sensitive G protein of neutrophils.
Becker EL; Kanaho Y; Kermode JC
Biomed Pharmacother; 1987; 41(6):289-97. PubMed ID: 3128340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
